The optimal management and treatment of pericardial effusion are still controversial. There is limited data related to the risk factors affecting survival in these patients. The aim of this study was to determine the risk factors affecting the survival rate of patients with symptomatic pericardial effusion who underwent surgical interventions.
INTRODUCTION
Pericardial effusion is a pathological accumulation of fluid within the pericardial space. This pathological process usually happens due to an imbalance in fluid formation and removal forces. The most common causes of large pericardial effusions are malignancy, infection, collagen vascular disease and chest radiation [1, 2] . Autopsy series revealed an incidence of 2-20% for pericardial effusion in patients with malignancy [3, 4] . The optimal management and treatment of pericardial effusion are still controversial. Many approaches have been described and applied for fluid drainage. Pericardiocentesis is a less-invasive technique performed under local anaesthesia and is useful in emergency situations to relieve symptoms; many patients, however, develop fluid reaccumulation within a short time after drainage. Subxiphoid pericardial window is a more invasive technique and requires general anaesthesia, but has less recurrence rates [5] . Survival rate should be considered as an important factor in managing pericardial effusion. There is a paucity of data on risk factors that determine survival in these patients. Most of the previous reports have studied survival rates only in a special group of these patients such as the cancer population. The survival rate in pericardial effusion due to other aetiologies like tuberculosis, acquired immunodeficiency syndrome (AIDS) and connective tissue diseases is less documented.
Moreover, there is an inconsistency between previous reports with regard to the determinant factors of poor outcome after surgery. Some studies have found underlying diseases to be the most important predictors of surgical outcome, while others have stated post-surgical complications to be the causes of poor survival after surgery [6, 7] .
The aim of this study was to determine the risk factors affecting the survival rate of patients with symptomatic pericardial effusion submitted to surgical intervention.
MATERIALS AND METHODS

Study population
From January 2004 to August 2011, we retrospectively reviewed the records of patients with pericardial effusion who underwent surgical intervention at the National Research Institute of Tuberculosis and Lung diseases (NRITLD); Masih Daneshvari Medical Center and Jamaran Medical Center, Tehran, Iran. Information on 153 patients was reviewed and recorded retrospectively. Of these patients, 116 were from Masih Daneshvari Hospital and 37 were from Jamaran Medical Center. The surgical technique, equipment and surgeons of the two participating centres were similar. Since the two centres in this study were referral hospitals, most of the patients were not from Tehran and hence our samples were obtained across the country. The entire study protocol was approved by the Medical Ethics Department of Shahid Beheshti University of Medical Sciences. Informed written consent was obtained from all patients.
Pericardial effusion was defined on the basis of clinical findings such as dyspnoea, hypotension, pulsus paradoxus, elevation of jugular pressure and tachycardia and/or echocardiographic or computed tomographic findings compatible with fluid accumulation in the pericardial space.
Patient characteristics were abstracted from the medical records. Findings that might act as potential risk factors were collected under five main categories: (i) demographic and clinical data; (ii) echocardiographic features; (iii) computed tomographic results; (iv) cytopathological reports and (v) surgical data. Demographic data and clinical findings included age, gender, dyspnoea, elevated jugular pressure, pulsus paradoxus and hypotension. Echocardiographic findings such as the right and left atrial collapse, right ventricular collapse and ejection fraction were also recorded. Positive computed tomographic findings included the presence of pericardial thickness, pericardial calcification, fluid or mass. Cytopathological findings including the primary diagnosis, cytological analysis of the effusion, and results of pericardial biopsy (if present) were obtained. The appearance and volume of the drained fluid were also recorded.
Surgical methods
For all patients, the surgical procedure was subxiphoid pericardial window. An incision was placed in the midline over the xiphoid process and then followed by an upward retraction. After direct incision of the pericardium, a sucker was inserted into the pericardial space to aspirate the fluid. A biopsy specimen was taken from the lower section of the anterior surface of the pericardium.
To induce anaesthesia, fentanyl, etomidate and rocuronium were administered. This regimen was followed by isoflurane or sevoflurane for maintenance. The mean duration of the operation was 30-45 min.
Follow-up. For the first month after the surgery, a close follow-up by a cardiologist was planned. Then, monthly visits by patients' family physicians were scheduled. All patients were followed up by phone calls after 1 year. This phone survey was repeated annually for the surviving patients. Previously, it was stated that follow-up accuracy of conventional questionnaire methods in the detection of complications is not different with a telephone follow-up in surgical patients [8] . In 11 patients (7.2%), we were unable to contact the patients by phone; therefore, we requested a search for these patients in local health centres. Using this method, we could contact 8 patients, and finally, just 3 (2%) patients were placed in the lost to follow-up group.
For follow-up purposes, the duration of survival was measured from baseline (surgery) to the date of the treatment failure (death) or to the date of the last follow-up (August 2011). By choosing August 2011, we ensured that all patients were followed for a minimum period of 12 months. Information on survival status, cause of death and date of death and overall survival were measured from the date of surgery.
Statistical analysis. Quantitative data are shown as mean ± standard deviation (SD), and qualitative data are presented as frequencies and percentages. The overall survival was calculated from the date of surgery until death or last follow-up. For univariate analysis, both unpaired t-test and χ 2 test were used to report any difference between the surviving patients and those who died during the follow-up period.
Multivariate Cox proportional hazards analysis was applied to predict the prognostic factors affecting survival in patients. Risk factors that showed significant effects in multivariate analysis were reported with hazard ratio (HR) and 95% confidence interval (CI). Survival curves were plotted by the Kaplan-Meier method. All statistical analyses were done with SPSS software. Statistical differences were considered significant if P<0.05.
RESULTS
Clinical and surgical profiles
Within the study period, 153 patients diagnosed with pericardial effusion underwent surgical intervention. Eighty-nine men and 64 women with a mean age of 50.3 ± 15.5 years (range 14-84) were investigated. Patients' demographics and underlying diseases of the participants showed no significant difference between the two hospitals.
The most prevalent symptoms among study participants were dyspnoea (n = 118), cough (n = 47), weight loss (n = 33) and oedema (n = 30). Concurrent malignancies were present in 66 (44%) patients. The most prevalent primary site for malignancy was lung (n = 36). Other primary sites of cancer included lymphoma (n = 9), breast (n = 7), ovary (n = 4), urinary bladder (n = 3), colorectal (n = 3), stomach (n = 2), central nervous system (n = 1) and unknown origin (n = 1). The clinical and demographic characteristics of patients regarding survival status are listed in Table 1 .
In 45 (30%) patients, urgent surgery was performed without a complete investigation. In these cases, diagnosis was made by clinical findings or with positive echocardiographic findings. Therefore, computed tomography was conducted on 105 (70%) patients. Among these patients, positive findings were found in 83. The most prevalent positive findings in computed tomography were pericardial effusion (n = 62), pleural effusion (n = 60) and lung or pericardial mass (n = 28). Echocardiographic information was available for 146 (97.3%) patients. The most common finding from echocardiographic information was the presence of massive effusions in the pericardial space (n = 92) followed by heart chambers' collapse (n = 61) and findings compatible with tamponade (n = 55). The mean ejection fraction was 51.6 ± 8.2%.
The mean volume of fluid drained during surgery was 752 ± 429 mL. The appearance of the effusion was grossly bloody in 69 (46%) and yellowish in 53 (35.3%) patients. In the remaining patients, the appearance of the fluid was purulent, turbid or unidentified.
Fluid samples were sent to the laboratory for cytological investigations in 113 (75.3%) patients. Cytological findings of 50 (33.3%) patients were consistent with malignancy. In 137 (91.3%) patients, a pericardial biopsy was done and sent to the laboratory for pathological investigations. Pathological findings of 38 (25.3%) patients were consistent with malignancy. In 30 (20%) patients, both cytological and pathological findings were consistent with malignancy. Imaging, cytopathological and effusion data of patients relating to survival status are summarized in Table 2 .
Follow-up outcomes
Median survival for all study participants was 15 (range 1-89 months). Patients who died after the surgery had a median follow-up of 8.5 months. At the last follow-up, the overall survival rate was 49.3%. The survival rate was 13.8% in patients with lung cancer, 30% with other malignancies and 69% with a benign disease. Our results showed 6-month, 1-year and 18-month survival rates of 85.6, 61.4 and 36.6%, respectively.
Univariate analysis
Univariate analysis (χ 2 test for nominal and t-test for interval variables) was used to find the relationship between potential risk factors and the survival rate. For 3 patients, follow-up data could not be achieved and hence data analyses were applied to 150 patients. Potential risk factors regarding patients' survival status are listed in Tables 1 and 2 . As shown in Table 1 , among clinical variables, weight loss was the only variable that shows significant difference between the survivors and non-survivors (P = 0.003). We also showed that the history of certain diseases may influence the outcome. The proportion of patients with underlying lung cancer and other organ cancers was significantly less in the group of survivors in comparison with the nonsurvivors (P < 0.001 and P = 0.024, respectively). Moreover, a positive history of chemoradiation therapy was also more prevalent in the non-survivors (P = 0.017). This is because patients with a positive history of cardiomyopathy were encountered more in the group of survivors (P = 0.003). Among echocardiographic features, the presence of massive effusion, chamber collapse and impending tamponade were statistically different between the survivors and non-survivors (P = 0.001, P < 0.001 and P = 0.001, respectively). For computed tomography, our analyses showed that the presence of mass and pleural effusion were the two findings that were more prevalent in the non-survivors (P = 0.028 and 0.047, respectively).
Identification of malignant cells on cytological evaluation of the effusion and pathological findings consistent with malignancy in tissue biopsies were significantly more frequent in non-survivors (P = 0.001 and 0.015, respectively). There was no statistically significant difference between the two groups regarding the appearance of the fluid.
Multivariate analysis
Risk factors that have a significant impact on survival (P < 0.05) were inserted in the multivariate Cox proportional hazards model. In this step, a positive history of lung cancer (HR 2.894, 95% CI 1.362-6.147, P = 0.006) or other cancers (HR 2.315, 95% CI 1.009-50311, P = 0.048), the presence of mass in the computed tomography (HR 1.985, 95% CI 1.100-3.581, P = 0.023) and echocardiographic findings compatible with tamponade (HR 1.745, 95% CI 1.048-2.906 P = 0.032) were the three independent predictors of postoperative death. Kaplan-Meier survival curves of patients with regard to the history of malignant disease, presentation of echocardiographic findings compatible with tamponade and the presence of a mass lesion detected by computed tomography are shown in Fig. 1 .
DISCUSSION
Pericardial effusion is a pathological accumulation of fluid in the pericardial cavity. If this accumulation occurs rapidly or progressively, it can lead to collapse of the heart chambers and tamponade, which is a life-threatening condition. Pericardial effusion can be seen in many conditions, but is a relatively common complication in patients with malignancy. Most of the previous publications have suggested subxiphoid pericardial window surgery as a prompt, easy and inexpensive procedure that can be applied for most of the effusions with a variety of aetiologies [9, 10] . Comparison between the surgical and non-surgical management of these patients is difficult because of the heterogeneity of the study population. In the present study, the subxiphoid pericardial window was used as the surgical intervention for all patients. Our study included 66 patients with a positive history of malignant disease and 87 with a benign aetiology. Lung cancer, haematological malignancies and breast cancer were the most common malignant diseases in the present study. The same distribution of primary malignant diseases was reported in previous reports [11] [12] [13] .
In our study, the survival rate was 49.3%. The poorest survival rate was 13.8% and was recorded in patients with lung cancer. This is while survival was more than twice as great in patients with other malignancies. Poor survival in pericardial effusion patients who underwent surgical intervention with underlying malignancy has been addressed in previous reports. In a review of 20 patients with lung cancer who developed pericardial effusion, conducted by Edoute et al. [14] , all of the patients died within 7 months after the diagnosis of pericardial effusion. Of these patients, 17 had died within 3 months. In another study, Wagner et al. [11] retrospectively reviewed 179 patients who had undergone pericardial window surgery. Overall survival for the lung cancer group in that study was poor (median survival of 5 months). In our study, since the number of cases in each cancer group was not sufficient, we separately reported the survival rate for lung cancer patients and pooled all other cancers in an 'other malignancies' group. In line with our findings, Wang et al. [12] showed that positive results for malignancy in cytological examination of the pericardial effusion would predict a poor prognosis. In that study, 50 patients with malignancy (mainly consisted of breast and lung cancer) were admitted to critical care unit because of large symptomatic pericardial effusions. High serum calcium and low albumin/globulin ratio were also considered to be other prognostic factors associated with a poor survival.
Intriguingly, in another study by Dosios et al. [5] , contrary to Wang's report and our study, there was no significant difference in the survival rates between patients with positive cytological or histological results for malignant invasion to the pericardium and those with unconfirmed pericardial invasion by a malignant disease. That study included 104 patients and proposed postoperative low cardiac output syndrome as a major predictor of early mortality. It seems Dosios's study is one of the sole reports that showed that the presence of malignancy has no statistically significant effect on the survival of these patients. Most of the previous reports, however, have shown a strong association between the presence of malignant pericardial effusion and poor survival.
The small number of patients with malignancies other than lung cancer in our research raises questions about the validity of the results, but the same conclusions are well established in previous reports. In a study published by Cullinane et al. [13] , it was shown that the presence of lung cancer is associated with a worse prognosis when compared with breast cancer, haematological malignancies or other solid tumour malignancies.
This study also examines the probable strength of imaging findings in the prediction of survival in patients with pericardial effusion. Indeed, the importance of underlying disease is a welldocumented risk factor for survival in patients who underwent surgical removal of the pericardial fluid [15] , but there are few reports regarding imaging findings as prognostic factors influencing survival in patients with pericardial effusion.
To the best of our knowledge, there is a paucity of data concerning the role of computed tomography in the prediction of survival in patients with pericardial effusion. Our study showed that detecting a lung or pericardial mass due to malignant disease in computed tomography, which might be an evidence of malignant invasion, could be a prognostic factor. In our cases, survival of patients with a macroscopic malignant invasion to heart, pericardium or mediastinum, as a detectable mass in computed tomography, was poorer than that of other patients.
Echocardiography is also a well accepted and widely applied technique of imaging for non-invasive diagnosis and evaluation of pericardial effusion. Our study illustrated a correlation between echocardiographic findings, particularly those compatible with tamponade and chamber collapse, and survival. So far, Wagner et al. [11] have shown that malignant effusion, volume of the drained fluid and presence of tamponade on echocardiogram are the three independent predictors of poor survival even after checking age, gender and histological characteristics in a logistic regression model. Similar results were obtained in our study with regard to the presence of tamponade on echocardiogram. On the other hand, in our study, although the drained volume was higher in non-survivors, this difference was not statistically significant. This inconsistency might be attributed to the effect of pericardial layers in fluid accumulation. In chronic accumulation of fluid, there is more time for the pericardium to stretch; hence, compensatory mechanisms could get ready with this delay. This is because in acute accumulation of fluid, a rapid increase in volume, first reaches the maximum threshold of the pericardial reserve volume and rapidly exceeds this limit of pericardial extension. After this stage, a disproportionate increase in the pericardial pressure with a little increase in the amount of volume would be inevitable [16] . Due to remodelling of pericardial layers and compensatory mechanisms in a setting of chronic pericardial effusion, the rate of fluid accumulation is more important than the fluid volume in determining clinical presentations of tamponade.
The present study has certain limitations. Retrospective and multicentre design, the absence of computed tomography findings in a large proportion of patients and telephone follow-up were some of the most important obstacles to this research. In order to have a good sample size, we had to use a multicentre design. To minimize the influence of confounders, the two hospitals were identical regarding surgical team and equipment. Our justification for using telephone survey as the preferred follow-up method, was a nationwide distribution of the study participants. In this setting, other follow-up techniques seemed unreasonable and impossible. We also did our best to gather all imaging documents, but in 45 cases, urgent surgery was necessary; hence, diagnosis was made by clinical or echocardiographic findings. Therefore, computed tomography information was available only in as much as 72% of our patients.
In conclusion, our findings in the present study show that in patients with pericardial effusion undergoing surgical removal of the fluid, underlying malignancy, the presence of a mass on computed tomography and echocardiographic findings compatible with tamponade are the three predictors of postoperative death. This study illustrated that patients with underlying malignant disease, especially with lung cancer or a detectable invasion of thorax in computed tomography, have a poor survival. Therefore, minimally invasive therapies should be considered as a more acceptable alternative for these high-risk patients. In addition, no clinical or demographic information could be indicated as an independent predictor of survival in these patients.
Unlike the wealth of present literature with regard to echocardiographic findings as a potential predictor of postoperation survival, the importance of computed tomography findings in predicting clinical outcomes in these patients is not well established. Hence, we suggest conducting new studies to delineate the capability of this imaging technique in predicting survival in patients with pericardial effusion. We have read with great interest the article by Mirhosseini et al. concerning risk factors affecting the survival rate in patients with symptomatic pericardial effusion undergoing surgical intervention [1] . They conclude that patients with underlying malignant diseases, particularly lung cancer or an invasion of the thorax, detected by computed tomography, have poor survival and are at a greater risk of postoperative death. Therefore, minimally-invasive therapies should be considered as a more acceptable alternative for these high-risk patients.
The aim of our brief comment is to highlight the advantages of pericardiocentesis followed by intrapericardial cisplatin administration in patients with cardiac tamponade due to lung cancer. At our centre, we consider pericardiocentesis and subsequent cisplatin administration as the method of choice for preventing recurrence of malignant pericardial effusion. Our results were documented in a 5-year study [2] .
In our study, death was attributed to generalized carcinomatosis causing respiratory failure in all patients. No patient died of recurrent cardiac tamponade. The main advantage of this treatment is that cisplatin infusion neither causes pain nor influences the haematological profile, because of the minimal systemic absorption from the pericardium. Intrapericardial fibrosis due to cisplatin infusion proved not to cause constrictive pericarditis even in long-term survivors.
Pericardiocentesis followed by intrapericardial administration of cisplatin is safe and effective in preventing the re-accumulation of malignant pericardial effusion in the majority of oncologic patients and should be the gold standard. In case of recurrence or diagnostic dilemmas, the creation of a pleuropericardial window through a mini-thoracotomy or a video-assisted thoracoscopic surgery procedure is the last alternative and is absolutely indicated.
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